NCT05871866

The Use of a Minimally Invasive Internal Fixation Device for Treatment of Unstable Pelvic Ring Fractures

Status unknown NA Last updated 23 May 2023

What this trial tests

NA trial testing minimally invasive internal fixation device "infix" in Unstable Pelvic Fractures in 20 participants. Status unknown.

Timeline

1 January 2023

Primary endpoint
1 January 2025

1 January 2025

Quick facts

Lead sponsor	Sohag University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	1 January 2023
Primary completion	1 January 2025
Estimated completion	1 January 2025
Sites	1 location across Egypt

Drugs / interventions tested

• minimally invasive internal fixation device "infix"

Conditions studied

• Unstable Pelvic Fractures — all drugs for Unstable Pelvic Fractures →

Sponsor

Sohag University

Who can join

Adults 18 to 60, any sex, with Unstable Pelvic Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pelvic fractures are common presentations to major trauma centers and are associated with significant morbidity in polytrauma patients. Traditional open reduction and internal fixation is associated with a high incidence of surgical morbidity, while external fixators, used for both temporary stabilisation and as definitive management, have a complication rate of up to 62% \[4\], with poor patient tolerance, pin site infection and aseptic loosening the more commonly documented complications in the literature.

Minimally invasive techniques have become more popular recently in the management of pelvic injuries due to their lower incidence of surgical morbidity. The application of a pelvic internal fixator (INFIX) has been presented as a comparable alternative to external fixation of anterior pelvic ring injuries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.